Case Summary:

• STARTED ON NABPACLITAXEL(D1,D8,D15) + CARBOPLATIN (D1)REGIMEN ON 17.7.2019

• POST 2 CYCLE- PET CT(30.8.2020) was suggestive of left upper lobe lesion 5.6 x 5.1 cm Abutting pleural encasing upper lobe bronchus, bony erosion Ist rib, abutting left CCA, subclavian areas of aorta, left BCV, mediastinal LN show regression

• Overall good response

• RECEIVED 1 MORE CYCLE(TOTAL 3)

• STARTED ON CTRT ON 30.9.2019 WITH WEEKLY PACLI(45MG/M2) AND CARBOPLATIN AUC2

• CTRT COMPLETED ON 6.11.2019

• CECT ON 18.11.2019 regression in size and wall thickening of cavitory mass lesion in left UL. Regression in size of enlarged LNs.

• STARTED ON DURVALUMAB 10MG/KG 2 WEEKLY FROM 22.11.2020

• POST 7 CYCLE DURVALUMAB , PET CT IN FEB 2020 SUGGEST NEAR COMPLETE RESOLUTION OF PREVIOUS LESION

• HAD GAP OF 3 MONTH FROM MARCH TO JULY 2020